Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -3.287% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CC(=O)Nc1ccccc1NC(=O)C/C(C)=N/NC(=O)c1ccccn1
(b) CCN(CC)c1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)CSc1cccc[n+]1[O-]
(c) CCc1cc(=O)oc2cc(C)c(CN3CCCC(C)C3)c(O)c12
Answer: c. CCc1cc(=O)oc2cc(C)c(CN3CCCC(C)C3)c(O)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1cc(=O)oc2cc(C)c(CN3CCCC(C)C3)c(O)c12
CCc1cc(=O)oc2cc(C)c(CN3CCCC(C)C3)c(O)c12
4-ethyl-5-hydroxy-7-methyl-6-[(3-methylpiperidin-1-yl)methyl]chromen-2-one